272 related articles for article (PubMed ID: 25266712)
1. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
Scott AD; Lee M; Kubba F; Chu A
Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
[No Abstract] [Full Text] [Related]
2. Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia.
Schwarz M; Kreuzer KA; Baskaynak G; Dörken B; le Coutre P
Eur J Haematol; 2002 Oct; 69(4):254-6. PubMed ID: 12431246
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia.
Brouard MC; Prins C; Mach-Pascual S; Saurat JH
Dermatology; 2001; 203(1):57-9. PubMed ID: 11549802
[TBL] [Abstract][Full Text] [Related]
4. Imatinib-induced pseudoporphyria.
Martinez-Mera C; Capusan TM; Herrero-Moyano M; Urquía Renke A; Steegmann Olmedillas JL; de Argila D
Clin Exp Dermatol; 2018 Jun; 43(4):463-466. PubMed ID: 29315788
[No Abstract] [Full Text] [Related]
5. [Acute generalized exanthematous pustulosis. Study of 22 cases].
Mebazaa A; Kort R; Zaiem A; Elleuch D; Moula H; Cheikhrouhou R; Trojjet S; Mokni M; Ben Osman A; Daghfous R
Tunis Med; 2010 Dec; 88(12):910-5. PubMed ID: 21136359
[TBL] [Abstract][Full Text] [Related]
6. A severe case of acute generalized exanthematous pustulosis (AGEP) in a child after the administration of amoxicillin-clavulanic acid: brief report.
Riten K; Shahina Q; Jeannette J; Palma-Diaz MF
Pediatr Dermatol; 2009; 26(5):623-5. PubMed ID: 19840330
[No Abstract] [Full Text] [Related]
7. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin induced acute generallised exanthematous pustulosis.
Foti C; Romita P; Zanframundo G; Mastrolonardo M; Angelini G; Calogiuri G; Nettis E; Bonamonte D
Indian J Pharmacol; 2017; 49(1):119-120. PubMed ID: 28458435
[TBL] [Abstract][Full Text] [Related]
9. Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia.
Shi CR; Nambudiri VE
Am J Hematol; 2018 Mar; 93(3):467-468. PubMed ID: 28836284
[No Abstract] [Full Text] [Related]
10. Two cases of amoxycillin-induced follicular acute localised exanthematous pustulosis.
Rajgopal Bala H; Jalilian C; Goh MS; Williams R; Tan G; Chong AH
Australas J Dermatol; 2017 Feb; 58(1):e23-e25. PubMed ID: 26552363
[TBL] [Abstract][Full Text] [Related]
11. A patient of chronic myelogenous leukemia developing painful rash on feet.
Kumar P; Das NK; Sil A; Chakrabarti P
J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
[No Abstract] [Full Text] [Related]
12. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
[No Abstract] [Full Text] [Related]
13. Acute generalized exanthematous pustulosis or toxic epidermal necrolysis?
Suárez-Amor O; Cabanillas M; Monteagudo B; Ramírez-Santos A; Pérez-Valcárcel J; De Las Heras C
Pediatr Dermatol; 2010; 27(5):559-60. PubMed ID: 21182651
[No Abstract] [Full Text] [Related]
14. Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up.
Dervis E; Ayer M; Akin Belli A; Barut SG
Eur J Dermatol; 2016 Apr; 26(2):133-7. PubMed ID: 26679005
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
Batrani M; Salhotra M; Kubba A; Agrawal M
Indian J Dermatol Venereol Leprol; 2016; 82(6):727-729. PubMed ID: 27716725
[No Abstract] [Full Text] [Related]
16. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
[No Abstract] [Full Text] [Related]
17. Imatinib mesylate induced erythroderma.
Sanghavi SA; Dongre AM; Khopkar US
Indian J Dermatol Venereol Leprol; 2012; 78(3):408. PubMed ID: 22565463
[No Abstract] [Full Text] [Related]
18. Acute generalized exanthematous pustulosis induced by docetaxel.
Ji YZ; Geng L; Qu HM; Zhou HB; Xiao T; Chen HD; Wei HC
Int J Dermatol; 2011 Jun; 50(6):763-5. PubMed ID: 21595682
[No Abstract] [Full Text] [Related]
19. Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.
Musolino C; Allegra A; Mannucci C; Russo S; Alonci A; Maisano V; Calapai G; Gangemi S
Turk J Haematol; 2015 Jun; 32(2):168-71. PubMed ID: 26316486
[TBL] [Abstract][Full Text] [Related]
20. Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
Kaygusuz-Atagunduz I; Toptas T; Yumuk F; Firatli-Tuglular T; Bayik M
J Cancer Res Ther; 2014; 10(4):1107-8. PubMed ID: 25579564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
